The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Zeinab Dalloul, Jana Grenel Briend, Mariama Diawara, Catherine Taylor, Rodney J. Ouellette. Leveraging liquid biopsy to uncover resistance mechanisms and guide personalized immunotherapy, Translational Oncology. 2025; 59: 102445102445. https://doi.org/10.1016/j.tranon.2025.102445 |
|
2 |
2026 |
N. Prabhu, V. Rajinikanth, Mathiyazhagan Narayanan. Neoantigen-driven cancer vaccines in personalized oncology: progress, obstacles, and translational prospects, Molecular Biology Reports. 2026; 53: 256. https://doi.org/10.1007/s11033-025-11421-2 |
|
3 |
2025 |
Volker Schirrmacher, Brain and Immune System Part II—An Integrative View upon Spatial Orientation, Learning, and Memory Function, International Journal of Molecular Sciences. 2025; 26: 11567. https://doi.org/10.3390/ijms262311567 |
|
4 |
2025 |
Faris Alrumaihi, Reem A. Alromaihi, Vikalp Kumar, Shehwaz Anwar. Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma, Current Issues in Molecular Biology. 2025; 47: 1056. https://doi.org/10.3390/cimb47121056 |
|
5 |
2026 |
Mohamed El-Tanani, Shakta Mani Satyam, Syed Arman Rabbani, Imran Rashid Rangraze, Ismail Ibrahim Ali Matalka, Frezah Muhana, Yahia El-Tanani, Alaa A. A. Aljabali, Mohammad Ahmed Khan, Suhel Parvez, Thantrira Porntaveetus. Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1, Discover Oncology. 2026; 17: 613. https://doi.org/10.1007/s12672-026-04852-1 |
|
6 |
2026 |
Muhammad Kamran Khan, M. Imad Khan Khalil, Yunjing Zhuo, Hao Liu, Jiahao Gu, Shiming Wang, Imam Hussain, Yang Liu, Yaseen Hussain, Rashid Khan, Zhenbo Tong, Zahid Hussain, Majid Ali, Muhammad Umar, Salim Ullah, Fu-Gen Wu, Hongtao Xu. Engineering the future of precision cancer immunotherapy: Integrating neoantigen biology, engineered delivery platforms, and clinical translation., Materials Today Advances. 2026; 30: 100808100808. https://doi.org/10.1016/j.mtadv.2026.100808 |
|
7 |
2025 |
Sourio Chakraborty, Udit Basak, Sumon Mukherjee, Sumoyee Mukherjee, Tanya Das. Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment, Cancer Control. 2025; 32: 10732748251381441. https://doi.org/10.1177/10732748251381441 |
|
8 |
2026 |
Daniel Ejim Uti, Esther Ugo Alum, Okechukwu Paul-Chima Ugwu. Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions, Cancer Treatment and Research Communications. 2026; 47: 101166101166. https://doi.org/10.1016/j.ctarc.2026.101166 |
|
9 |
2026 |
Kehinde Alare, Tope Odunitan, Taiwo Alare, Tirenioluwa Ojo, Folasade Alare, Uthman Uthman. Integrating biocomputational techniques for vaccine development for glioblastoma multiforme: a possible way of enhancing precision, Frontiers in Immunology. 2026; 17: 1835999. https://doi.org/10.3389/fimmu.2026.1835999 |